Orwin John A 4
4 · ANAPTYSBIO, INC · Filed Sep 17, 2024
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Orwin John A
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-15+1,300→ 3,335 total - Exercise/Conversion
Restricted Stock Unit
2024-09-15−1,300→ 2,600 total→ Common Stock (1,300 underlying)
Footnotes (2)
- [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date.